SATB1 and cancer: The antitumor effects of baicalein are mediated through various signaling pathways, including NF-κB, PI3K/Akt, mTOR, and TGF-β/Smad (189, 192, 194, 195), making it a promising therapeutic agent for targeting SATB1 in cancer treatment.